Site Members can sign up for company wide alerts
Lawsuit Overview
<p align= justify >The original Complaint alleges that during the Class Period defendants, GlaxoSmithKline PLC and certain of its officers, violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 by publicly issuing a series of false and misleading statements regarding Avandia, GSK’s popular diabetes drug.</p> <p align= justify > </p> <p al...
You must register (for free) or login to view the entire case.